METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

Clinical trials for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) trials appear

Sign up with your email to follow new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 2 Not yet finished but already full! 5 Completed 1

AI model predicts prostate cancer treatment success from scans

Knowledge-focused Completed

This study looked back at medical records and PET scans from 168 men with advanced prostate cancer who received standard first-line treatment. Researchers created a prediction model that combines scan results with patient information to estimate how quickly and effectively treatm…

Matched conditions: METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:38 UTC

METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

Get alerted when new METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) trials appear

AI model predicts prostate cancer treatment success from scans